Literature DB >> 23684893

Spongiacidin C, a pyrrole alkaloid from the marine sponge Stylissa massa, functions as a USP7 inhibitor.

Michitaka Yamaguchi1, Mitsue Miyazaki, Matthew P Kodrasov, Henki Rotinsulu, Fitje Losung, Remy E P Mangindaan, Nicole J de Voogd, Hideyoshi Yokosawa, Benjamin Nicholson, Sachiko Tsukamoto.   

Abstract

USP7, a deubiquitylating enzyme hydrolyzing the isopeptide bond at the C-terminus of ubiquitin, is an emerging cancer target. We isolated spongiacidin C from the marine sponge Stylissa massa as the first USP7 inhibitor from a natural source. This compound inhibited USP7 most strongly with an IC50 of 3.8 μM among several USP family members tested.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684893     DOI: 10.1016/j.bmcl.2013.04.066

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

Review 1.  Decision for cell fate: deubiquitinating enzymes in cell cycle checkpoint.

Authors:  Key-Hwan Lim; Myoung-Hyun Song; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2016-01-13       Impact factor: 9.261

2.  Ceylonins G-I: spongian diterpenes from the marine sponge Spongia ceylonensis.

Authors:  Ahmed H El-Desoky; Hikaru Kato; Sachiko Tsukamoto
Journal:  J Nat Med       Date:  2017-05-03       Impact factor: 2.343

Review 3.  Regulation of protein stability of DNA methyltransferase 1 by post-translational modifications.

Authors:  Anthony Scott; Jing Song; Rob Ewing; Zhenghe Wang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2014-01-03       Impact factor: 3.848

4.  Composition and Predictive Functional Analysis of Bacterial Communities in Seawater, Sediment and Sponges in the Spermonde Archipelago, Indonesia.

Authors:  Daniel F R Cleary; Nicole J de Voogd; Ana R M Polónia; Rossana Freitas; Newton C M Gomes
Journal:  Microb Ecol       Date:  2015-06-14       Impact factor: 4.552

5.  Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.

Authors:  Ilaria Lamberto; Xiaoxi Liu; Hyuk-Soo Seo; Nathan J Schauer; Roxana E Iacob; Wanyi Hu; Deepika Das; Tatiana Mikhailova; Ellen L Weisberg; John R Engen; Kenneth C Anderson; Dharminder Chauhan; Sirano Dhe-Paganon; Sara J Buhrlage
Journal:  Cell Chem Biol       Date:  2017-10-19       Impact factor: 8.116

6.  Molecular basis of USP7 inhibition by selective small-molecule inhibitors.

Authors:  Andrew P Turnbull; Stephanos Ioannidis; Wojciech W Krajewski; Adan Pinto-Fernandez; Claire Heride; Agnes C L Martin; Louise M Tonkin; Elizabeth C Townsend; Shane M Buker; David R Lancia; Justin A Caravella; Angela V Toms; Thomas M Charlton; Johanna Lahdenranta; Erik Wilker; Bruce C Follows; Nicola J Evans; Lucy Stead; Cristina Alli; Vladislav V Zarayskiy; Adam C Talbot; Alexandre J Buckmelter; Minghua Wang; Crystal L McKinnon; Fabienne Saab; Joanna F McGouran; Hannah Century; Malte Gersch; Marc S Pittman; C Gary Marshall; Tony M Raynham; Mary Simcox; Lorna M D Stewart; Sheila B McLoughlin; Jaime A Escobedo; Kenneth W Bair; Christopher J Dinsmore; Tim R Hammonds; Sunkyu Kim; Sylvie Urbé; Michael J Clague; Benedikt M Kessler; David Komander
Journal:  Nature       Date:  2017-10-18       Impact factor: 49.962

Review 7.  Advances in the Development Ubiquitin-Specific Peptidase (USP) Inhibitors.

Authors:  Shiyao Chen; Yunqi Liu; Huchen Zhou
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

Review 8.  Deubiquitinases and the new therapeutic opportunities offered to cancer.

Authors:  Roland Pfoh; Ira Kay Lacdao; Vivian Saridakis
Journal:  Endocr Relat Cancer       Date:  2015-02       Impact factor: 5.678

Review 9.  Cell death and deubiquitinases: perspectives in cancer.

Authors:  Seemana Bhattacharya; Mrinal Kanti Ghosh
Journal:  Biomed Res Int       Date:  2014-07-09       Impact factor: 3.411

Review 10.  Marine low molecular weight natural products as potential cancer preventive compounds.

Authors:  Valentin A Stonik; Sergey N Fedorov
Journal:  Mar Drugs       Date:  2014-01-27       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.